TY - JOUR
T1 - Absence of clinically relevant growth acceleration in untreated children with non-classical congenital adrenal hyperplasia
AU - Pijnenburg-Kleizen, Karijn J.
AU - Borm, George F.
AU - Otten, Barto J.
AU - Schott, Dina A.
AU - Van Den Akker, Erica L.
AU - Stokvis-Brantsma, Wilhelmina H.
AU - Voorhoeve, Paul G.
AU - Bakker, Boudewijn
AU - Claahsen-Van Der Grinten, Hedi L.
PY - 2012/5
Y1 - 2012/5
N2 - Background/Aims: In classical congenital adrenal hyperplasia (CAH), elevation of adrenal androgens leads to accelerated growth and bone maturation with compromised adult height. In untreated children with non-classical CAH (NC-CAH), in which adrenal androgens are generally only slightly increased, growth velocity may not be significantly elevated. Methods: Twenty-four patients were included and divided into a symptomatic and an asymptomatic group. Height was expressed as height standard deviation scores (HSDS) and corrected for target height (HSDS-THSDS). Bone maturation was expressed as bone age acceleration (BA c = bone age - calendar age). Linear mixed models with random factor patient were used for the analysis of growth and bone age. Results: In symptomatic patients (n = 17), HSDS-THSDS only slightly increased by 0.06 SDS per year (95% CI 0.02-0.10). Mean BA c was 2.21 years (SDS 0.66, p < 0.0001). In asymptomatic patients (n = 7), no significant growth acceleration or BA c was found. Conclusions: In untreated NC-CAH children, growth acceleration is small and generally not visible on their growth charts. BA c is more pronounced. Therefore, the absence of an increase in growth velocity does not exclude the diagnosis of NC-CAH. When considering this diagnosis, bone age acceleration should also be taken into account.
AB - Background/Aims: In classical congenital adrenal hyperplasia (CAH), elevation of adrenal androgens leads to accelerated growth and bone maturation with compromised adult height. In untreated children with non-classical CAH (NC-CAH), in which adrenal androgens are generally only slightly increased, growth velocity may not be significantly elevated. Methods: Twenty-four patients were included and divided into a symptomatic and an asymptomatic group. Height was expressed as height standard deviation scores (HSDS) and corrected for target height (HSDS-THSDS). Bone maturation was expressed as bone age acceleration (BA c = bone age - calendar age). Linear mixed models with random factor patient were used for the analysis of growth and bone age. Results: In symptomatic patients (n = 17), HSDS-THSDS only slightly increased by 0.06 SDS per year (95% CI 0.02-0.10). Mean BA c was 2.21 years (SDS 0.66, p < 0.0001). In asymptomatic patients (n = 7), no significant growth acceleration or BA c was found. Conclusions: In untreated NC-CAH children, growth acceleration is small and generally not visible on their growth charts. BA c is more pronounced. Therefore, the absence of an increase in growth velocity does not exclude the diagnosis of NC-CAH. When considering this diagnosis, bone age acceleration should also be taken into account.
KW - Bone age acceleration
KW - Bone development
KW - Growth
KW - Non-classical congenital adrenal hyperplasia
UR - http://www.scopus.com/inward/record.url?scp=84859649901&partnerID=8YFLogxK
U2 - 10.1159/000337217
DO - 10.1159/000337217
M3 - Article
C2 - 22508177
AN - SCOPUS:84859649901
SN - 1663-2818
VL - 77
SP - 164
EP - 169
JO - Hormone Research in Paediatrics
JF - Hormone Research in Paediatrics
IS - 3
ER -